Montalban-Bravo, G., Takahashi, K., Patel, K., Wang, F., Xingzhi, S., Nogueras, G. M., . . . Garcia-Manero, G. (2018). Impact of the number of mutations in survival and response outcomes to hypomethylating agents in patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Oncotarget.
Citación estilo ChicagoMontalban-Bravo, Guillermo, et al. "Impact of the Number of Mutations in Survival and Response Outcomes to Hypomethylating Agents in Patients With Myelodysplastic Syndromes or Myelodysplastic/myeloproliferative Neoplasms." Oncotarget 2018.
Cita MLAMontalban-Bravo, Guillermo, et al. "Impact of the Number of Mutations in Survival and Response Outcomes to Hypomethylating Agents in Patients With Myelodysplastic Syndromes or Myelodysplastic/myeloproliferative Neoplasms." Oncotarget 2018.